Gemcitabine Hydrochloride

CAS 122111-03-9 10 FDA-DMF suppliersSmall Molecule

Overview

Gemcitabine Hydrochloride is a nucleoside analog used as chemotherapy. It is primarily utilized in the treatment of various carcinomas, including non-small cell lung cancer and pancreatic cancer.

API suppliers (8)

Suppliers of Gemcitabine Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • PharmaEssentia
  • Ono Pharmaceutical Co., Ltd.Japan
  • FRESENIUS KABI ONCOLOGY LTD
  • OLON SPAItaly
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD
  • EUTICALS SPAItaly

Chemical identity

IUPAC name
17-ethyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene
Canonical SMILES
CCC1CCC2C1(CCC3C2CCC4C3(CCCC4)C)C
InChIKey
JWMFYGXQPXQEEM-UHFFFAOYSA-N

Therapeutic areas

OncologyHematology

Related APIs

Deferasirox
24 suppliers
Azacitidine
21 suppliers
Lenalidomide
20 suppliers
Ibrutinib
16 suppliers
Busulfan
10 suppliers
Midostaurin
10 suppliers
Ixazomib
7 suppliers
Romidepsin
6 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo